A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

被引:41
|
作者
Benotmane, Ilies [1 ]
Bruel, Timothee [2 ,3 ]
Planas, Delphine [2 ,3 ]
Fafi-Kremer, Samira [4 ]
Schwartz, Olivier [2 ,3 ]
Caillard, Sophie [1 ]
机构
[1] Strasbourg Univ Hosp, Dept Nephrol & Transplantat, 1 Pl hop, F-67091 Strasbourg, France
[2] Univ Paris, Ctr Natl Rech scientif CNRS, Virus & Immun Unit, Unite mixte Rech UMR 3569,Inst Pasteur, Paris, France
[3] Vaccine Res Inst, Basic Div, Creteil, France
[4] Strasbourg Univ Hosp, Dept Virol, Strasbourg, France
关键词
Delta variant; fourth dose; kidney transplantation; mRNA vaccine; neutralizing antibodies; SARS-CoV-2;
D O I
10.1016/j.kint.2022.02.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1073 / 1076
页数:4
相关论文
共 50 条
  • [31] Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
    Hall, Victoria G.
    Ferreira, Victor H.
    Ierullo, Matthew
    Ku, Terrance
    Marinelli, Tina
    Majchrzak-Kita, Beata
    Yousuf, Anila
    Kulasingam, Vathany
    Humar, Atul
    Kumar, Deepali
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (12) : 3980 - 3989
  • [32] COMPARISON OF MRNA-1273 AND BNT16B2 SARS-COV-2 MRNA VACCINE IMMUNOGENICITY IN KIDNEY TRANSPLANT PATIENTS
    Cejka, Daniel
    Kaiser, Robert A.
    Langthaler, Simon
    Apfalter, Petra
    Kerschner, Heidrun
    Haller, Maria C.
    TRANSPLANT INTERNATIONAL, 2021, 34 : 30 - 30
  • [33] Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine
    Koutlas, Ioannis G.
    Camara, Renee
    Argyris, Prokopios P.
    Davis, Mark Denis P.
    Miller, Daniel D.
    ORAL DISEASES, 2022, 28 : 2612 - 2613
  • [34] Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
    Hung Fu Tseng
    Bradley K. Ackerson
    Yi Luo
    Lina S. Sy
    Carla A. Talarico
    Yun Tian
    Katia J. Bruxvoort
    Julia E. Tubert
    Ana Florea
    Jennifer H. Ku
    Gina S. Lee
    Soon Kyu Choi
    Harpreet S. Takhar
    Michael Aragones
    Lei Qian
    Nature Medicine, 2022, 28 : 1095 - 1095
  • [35] Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
    Corbett, Kizzmekia S.
    Nason, Martha C.
    Flach, Britta
    Gagne, Matthew
    O' Connell, Sarah
    Johnston, Timothy S.
    Shah, Shruti N.
    Edara, Venkata Viswanadh
    Floyd, Katharine
    Lai, Lilin
    McDanal, Charlene
    Francica, Joseph R.
    Flynn, Barbara
    Wu, Kai
    Choi, Angela
    Koch, Matthew
    Abiona, Olubukola M.
    Werner, Anne P.
    Moliva, Juan, I
    Andrew, Shayne F.
    Donaldson, Mitzi M.
    Fintzi, Jonathan
    Flebbe, Dillon R.
    Lamb, Evan
    Noe, Amy T.
    Nurmukhambetova, Saule T.
    Provost, Samantha J.
    Cook, Anthony
    Dodson, Alan
    Faudree, Andrew
    Greenhouse, Jack
    Kar, Swagata
    Pessaint, Laurent
    Porto, Maciel
    Steingrebe, Katelyn
    Valentin, Daniel
    Zouantcha, Serge
    Bock, Kevin W.
    Minai, Mahnaz
    Nagata, Bianca M.
    van de Wetering, Renee
    Boyoglu-Barnum, Seyhan
    Leung, Kwanyee
    Shi, Wei
    Yang, Eun Sung
    Zhang, Yi
    Todd, John-Paul M.
    Wang, Lingshu
    Alvarado, Gabriela S.
    Andersen, Hanne
    SCIENCE, 2021, 373 (6561) : 1325 - +
  • [36] BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
    Patrick Tang
    Mohammad R. Hasan
    Hiam Chemaitelly
    Hadi M. Yassine
    Fatiha M. Benslimane
    Hebah A. Al Khatib
    Sawsan AlMukdad
    Peter Coyle
    Houssein H. Ayoub
    Zaina Al Kanaani
    Einas Al Kuwari
    Andrew Jeremijenko
    Anvar Hassan Kaleeckal
    Ali Nizar Latif
    Riyazuddin Mohammad Shaik
    Hanan F. Abdul Rahim
    Gheyath K. Nasrallah
    Mohamed Ghaith Al Kuwari
    Hamad Eid Al Romaihi
    Adeel A. Butt
    Mohamed H. Al-Thani
    Abdullatif Al Khal
    Roberto Bertollini
    Laith J. Abu-Raddad
    Nature Medicine, 2021, 27 : 2136 - 2143
  • [37] BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
    Tang, Patrick
    Hasan, Mohammad R.
    Chemaitelly, Hiam
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    AlMukdad, Sawsan
    Coyle, Peter
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Al Romaihi, Hamad Eid
    Butt, Adeel A.
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    NATURE MEDICINE, 2021, 27 (12) : 2136 - +
  • [38] Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants
    Pegu, Amarendra
    O'Connell, Sarah
    Schmidt, Stephen D.
    O'Dell, Sijy
    Talana, Chloe A.
    Lai, Lilin
    Albert, Jim
    Anderson, Evan
    Bennett, Hamilton
    Corbett, Kizzmekia S.
    Flach, Britta
    Jackson, Lisa
    Leav, Brett
    Ledgerwood, Julie E.
    Luke, Catherine J.
    Makowski, Mat
    Roberts, Paul C.
    Roederer, Mario
    Rebolledo, Paulina A.
    Rostad, Christina A.
    Rouphael, Nadine G.
    Shi, Wei
    Wang, Lingshu
    Widge, Alicia T.
    Yang, Eun Sung
    Beigel, John H.
    Graham, Barney S.
    Mascola, John R.
    Suthar, Mehul S.
    McDermott, Adrian
    Doria-Rose, Nicole A.
    SCIENCE, 2021, 373 (6561) : 1372 - +
  • [39] Impact of demographics on the inmunogenicity after the third dose of the mRNA-1273 vaccine against the SARS-CoV-2 in cancer patients
    Jimenez Ortega, A.
    Benitez Fuentes, J.
    de Luna Aguilar, A.
    Flores Navarro, P.
    Bartolome Arcilla, J.
    Baos Munoz, E.
    Delgado-Iribarren Garcia-Campero, A.
    Gil Useros, S.
    Perez Segura, P.
    Sanchez-Ramon, S.
    Mohamed Mohamed, K.
    Guevara-Hoyer, K.
    Garcia Bravo, L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S63 - S63
  • [40] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Anderson, E. J.
    Rouphael, N. G.
    Widge, A. T.
    Jackson, L. A.
    Roberts, P. C.
    Makhene, M.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A. B.
    Flach, B.
    Lin, B. C.
    Doria-Rose, N. A.
    O'Dell, S.
    Schmidt, S. D.
    Corbett, K. S.
    Swanson, P. A., II
    Padilla, M.
    Neuzil, K. M.
    Bennett, H.
    Leav, B.
    Makowski, M.
    Albert, J.
    Cross, K.
    Edara, V. V.
    Floyd, K.
    Suthar, M. S.
    Martinez, D. R.
    Baric, R.
    Buchanan, W.
    Luke, C. J.
    Phadke, V. K.
    Rostad, C. A.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2427 - 2438